DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2249871/reasons-to-retain-pacbio-pacb-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2249871 Apr 03, 2024 - PacBio's (PACB) strong product demand and top-line growth raise optimism about the stock. 0

https://www.zacks.com/stock/news/2240028/pacbio-s-pacb-new-panel-to-aid-its-clinical-research-solution?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240028 Mar 13, 2024 - PacBio (PACB) announces the PureTarget repeat expansion panel, which is the HiFi long-read sequencing that supports comprehensive analysis of 20 genes associated with neurological diseases. 0

https://www.zacks.com/stock/news/2227228/pacific-biosciences-pacb-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2227228 Feb 15, 2024 - While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. 0

https://www.zacks.com/stock/news/2227162/pacific-biosciences-of-california-pacb-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2227162 Feb 15, 2024 - Pacific Biosciences (PACB) delivered earnings and revenue surprises of 12.90% and 0.20%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://seekingalpha.com/news/4056668-cantor-picks-rcel-as-best-2024-medtech-idea-bullish-on-pacb-axgn-cers?source=feed_sector_healthcare Jan 21, 2024 - Cantor Fitzgerald picks AVITA Medical (RCEL) as its best 2024 medtech idea, while remaining bullish on AXGN, CERS, ELUT, XGN, NNOX, NPCE, NYXH, SIBN, and PACB. Read more here. 0

https://www.zacks.com/stock/news/2210985/pacbio-s-pacb-new-pandna-kit-ready-to-boost-dna-extraction?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2210985 Jan 16, 2024 - PacBio's (PACB) new offering, PanDNA kit, is likely to help researchers effectively extract DNA optimized for HiFi sequencing. This versatile Nanobind kit is expected to be available in February 2024. 0

https://www.zacks.com/stock/news/2202089/reasons-to-retain-pacbio-pacb-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202089 Dec 26, 2023 - PacBio's (PACB) product development activities raise optimism about the stock. 0